Supportive Oncology Care at Home Post-Discharge
Completed · Not applicable
Conditions studied: Cancer
In brief
This study is evaluating if a program that involves remote monitoring and home-based care may improve the post-discharge care of recently hospitalized patients with advanced cancer. The Supportive Oncology Care at Home intervention consists of three key components: 1. Remote patient monitoring (e.g. patient-reported symptoms, home-monitored vital signs and body weight); 2. A Medically Home care model for symptom assessment, evaluation, and management (e.g. triggers for phone calls and visits to patients' homes to address and manage any concerning issues identified); 3. Structured communication with the oncology team to ensure continuity of care.
Key facts
- Study ID
- NCT04637035
- Run by
- Massachusetts General Hospital
- People needed
- 52
- Starts
- 2021-08-19
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2026-06-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient Eligibility
- Age 18 or older
- Diagnosed with advanced cancer (defined as receiving treatment with palliative intent per chemotherapy order entry treatment intent designation and/or trial consent forms OR based on documentation in the oncology clinic notes for those not receiving chemotherapy)
- Admitted with an unplanned or non-elective hospitalization at Massachusetts General Hospital (MGH)
- Not requiring ICU-level care during their hospitalization
- Receiving care at the MGH Cancer Center
- Ability to read and respond to question in English
- Residing within 50 miles of MGH.
- Caregiver Eligibility
- Relative or friend of eligible patient
- Verbally fluent in English
- Age 18 or older
- Clinician Eligibility
- - Outpatient oncology physicians and advanced practice clinicians who care for patients that receive the Supportive Oncology Care at Home intervention
You may not qualify if…
- Patient Exclusion
- Are admitted to the intensive care unit
- Have a high oxygen requirement (FIO2 > 0.40)
- Experience active angina or cardiac arrythmias
- Have a planned inpatient surgical or interventional procedure
- Have uncontrolled psychiatric illness or impaired cognition interfering with their ability to understand study procedures and provide written informed consent
- Are deemed ineligible for home-based care based on the inpatient oncology clinician assessment
- Are planning to be discharged to hospice or to any location other than their home
- Caregiver Exclusion -- Caregivers who are unwilling or unable to participate in the study.
- Clinician Exclusion
- - Clinicians who are unwilling or unable to participate in the study.
Where it is running
- Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.